Observe Medical Asa

OBSRV · OL · Healthcare / Medical Devices

0.79NOK-0.04 (-5.05%)

Price History

Full chart

Market Stats

Previous Close0.832

Open0.80

Day Range0.772 – 0.834

52-Week Range0.53 – 1.39

Volume120.66K

Market Cap126.62M

P/E (TTM)3.10

Forward P/E0.00

EPS0.30

Dividend Yield0.00%

Beta0.05

50-Day Avg0.9738

200-Day Avg0.9687

About

Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control. Observe Medical ASA was founded in 2009 and is headquartered in Oslo, Norway.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Jorgen Mann
Employees5
HeadquartersDronning Eufemias gate 16, Oslo, Norway, 0191, Norway
Websitehttps://observemedical.com

Leadership

Mr. Jorgen MannChief Executive Officer
Mr. Johan M. FagerliChief Financial Officer

Financials

Income Statement

Currency: NOK	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	614.31K	197.77K	106.19K	176.65K	2.96M	24.04M	19.52M	27.94M	18.48M	18.81M
Growth (%)	-	-67.81%	-46.31%	+66.36%	+1576.20%	+711.96%	-18.80%	+43.14%	-33.85%	+1.77%
Cost of Revenue	387.64K	1.37M	-474.98K	636.78K	1.98M	14.52M	14.34M	18.66M	15.41M	14.11M
Gross Profit	226.67K	-1.18M	581.16K	-460.13K	986.00K	9.52M	5.18M	9.29M	3.07M	4.70M
Gross Margin	36.90%	-595.02%	547.31%	-260.48%	33.30%	39.59%	26.52%	33.24%	16.63%	24.98%
Operating Expense	14.87M	13.79M	12.31M	15.33M	29.07M	46.06M	64.32M	62.28M	115.60M	83.76M
Operating Income	-14.64M	-14.97M	-11.72M	-15.79M	-28.09M	-36.54M	-59.14M	-53.00M	-112.53M	-79.06M
Operating Margin	-2383.72%	-7569.62%	-11041.04%	-8936.68%	-948.50%	-152.00%	-302.97%	-189.67%	-608.81%	-420.31%
EBITDA	-	-13.04M	6.59M	-11.36M	-31.17M	-19.53M	-35.98M	-114.28M	-34.80M	-30.15M
EBITDA Margin	-	-6592.50%	6206.85%	-6429.38%	-1052.82%	-81.24%	-184.29%	-408.98%	-188.26%	-160.28%
Net Income	-10.57M	-17.37M	2.27M	-16.92M	-36.87M	-26.32M	-50.80M	-63.89M	-126.97M	-48.64M
Net Income Margin	-1720.81%	-8782.87%	2141.22%	-9576.73%	-1245.12%	-109.48%	-260.24%	-228.65%	-686.93%	-258.57%
Interest Expense	0	0	416.07K	1.27M	2.53M	3.33M	3.82M	6.65M	10.60M	5.17M
Interest Expense % of Total Revenue	0.00%	0.00%	391.84%	721.54%	85.48%	13.83%	19.56%	23.80%	57.34%	27.48%

Balance Sheet

Currency: NOK	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	69.04M	64.04M	58.83M	55.33M	87.73M	71.74M	215.81M	244.82M	148.41M	101.17M
Total Liabilities	54.34M	52.64M	42.01M	40.79M	67.39M	85.86M	77.51M	132.74M	124.30M	71.21M
Total Equity	14.70M	11.39M	16.82M	14.54M	20.35M	-14.12M	138.31M	112.08M	24.11M	29.96M
Cash	3.51M	2.06M	621.14K	485.21K	18.95M	2.86M	13.64M	13.68M	1.98M	11.50M
Net Debt	-	20.75M	24.41M	24.93M	15.88M	3.65M	32.11M	40.83M	84.18M	19.24M

Cash Flow

Currency: NOK	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-10.45M	-9.83M	-8.36M	-13.97M	-21.64M	-22.13M	-51.37M	-24.45M	-30.68M	-24.83M
Investing Cash Flow	-1.41M	-1.57M	-1.95M	-2.14M	-8.08M	-4.89M	-58.37M	-7.63M	-724.00K	-1.14M
Financing Cash Flow	14.33M	11.81M	9.56M	16.19M	48.17M	16.08M	120.98M	31.74M	17.53M	35.43M
Capital Expenditure	1.41M	1.57M	2.14M	2.14M	1.24M	4.89M	4.93M	8.02M	1.84M	1.14M
Free Cash Flow	-	-11.40M	-10.31M	-16.11M	-22.88M	-27.01M	-56.26M	-32.47M	-32.52M	-25.97M
FCF to OCF	-	115.96%	123.31%	115.32%	105.73%	122.08%	109.52%	132.79%	106.00%	104.59%

Earnings

Report Date	Mar 31, 2020	Jun 30, 2020	Nov 3, 2020	Dec 31, 2020	May 12, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Jun 30, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-0.11	-2.97	-0.36	-4.69	-0.25	0.31	-1.94	-3.41	-0.95	-0.86	-1.55	-1.98	-3.12
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap126.62M

Enterprise Value163.29M

Trailing P/E3.10

Forward P/E0.00

Price / Sales5.78

Price / Book4.39

EPS0.30

Book Value0.211

Revenue (TTM)21.91M

Gross Profit (TTM)5.99M

EBITDA-27.33M

Profit Margin-109.68%

Operating Margin-74.43%

Return on Equity-145.47%

Return on Assets-17.94%

Shares Outstanding136.15M

Shares Float27.43M

Beta0.05

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jan 14, 20251:15